T1	PROC 2594 2601	tratado
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	PROC 59 91	evaluará la eficacia y seguridad
T3	PROC 99 107	terapias
#2	AnnotatorNotes T3	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T4	PROC 133 145	tratamientos
#3	AnnotatorNotes T4	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T5	DISO 165 204	Cáncer de Pulmón de Células no pequeñas
#4	AnnotatorNotes T5	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T6	DISO 243 263	mutaciones somáticas
#5	AnnotatorNotes T6	C0544886; Somatic mutation; Cell or Molecular Dysfunction
T7	ANAT 301 307	sangre
#6	AnnotatorNotes T7	C0005767; Blood; Body Substance
T8	PROC 338 375	ESTUDIO DE FASE II/III, MULTICÉNTRICO
T9	PROC 382 416	EVALUAR LA EFICACIA Y LA SEGURIDAD
#7	AnnotatorNotes T9	C0511730; Identify product efficacy and safety issues; Health Care Activity
T10	PROC 430 438	TERAPIAS
#8	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T11	PROC 454 465	TRATAMIENTO
#9	AnnotatorNotes T11	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T12	DISO 485 516	CÁNCER DE PULMÓN NO MICROCÍTICO
#10	AnnotatorNotes T12	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T13	DISO 518 522	CPNM
#11	AnnotatorNotes T13	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T14	DISO 561 581	MUTACIONES SOMÁTICAS
#12	AnnotatorNotes T14	C0544886; Somatic mutation; Cell or Molecular Dysfunction
T15	DISO 705 716	metastásico
#13	AnnotatorNotes T15	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T16	ANAT 608 614	SANGRE
#14	AnnotatorNotes T16	C0005767; Blood; Body Substance
T17	PROC 631 662	ANÁLISIS DE SCREENING EN SANGRE
T18	ANAT 656 662	SANGRE
#15	AnnotatorNotes T18	C0005767; Blood; Body Substance
T19	DISO 689 693	CPNM
#16	AnnotatorNotes T19	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T20	DISO 723 739	cáncer de pulmón
#17	AnnotatorNotes T20	C0242379; Malignant neoplasm of lung; Neoplastic Process | C0684249; Carcinoma of lung; Neoplastic Process
T21	ANAT 784 792	pulmones
#18	AnnotatorNotes T21	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T22	ANAT 801 808	órganos
#19	AnnotatorNotes T22	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T23	DISO 834 865	CÁNCER DE PULMÓN NO MICROCÍTICO
#20	AnnotatorNotes T23	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T24	DISO 867 871	CPNM
#21	AnnotatorNotes T24	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T25	DISO 934 938	CPNM
#22	AnnotatorNotes T25	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T26	PROC 1002 1028	quimiorradiación combinada
T27	PROC 1075 1086	diagnóstico
#23	AnnotatorNotes T27	C0011900; Diagnosis; Diagnostic Procedure
T28	DISO 1223 1241	Enfermedad medible
#24	AnnotatorNotes T28	C1513041; Measurable Disease; Disease or Syndrome
T29	PROC 1355 1384	tratamiento sistémico o local
T30	DISO 1406 1412	cáncer
#25	AnnotatorNotes T30	C0006826; Malignant Neoplasms; Neoplastic Process
T31	ANAT 1426 1433	órganos
#26	AnnotatorNotes T31	C0178784; Organ; Body Part, Organ, or Organ Component | C1280836; Entire body organ; Body Part, Organ, or Organ Component
T32	PROC 1562 1585	métodos anticonceptivos
#27	AnnotatorNotes T32	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T33	CHEM 1647 1659	medicamentos
#28	AnnotatorNotes T33	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T34	PROC 1784 1794	evaluación
#29	AnnotatorNotes T34	C1261322; Evaluation procedure; Health Care Activity
T35	PROC 1799 1823	tomografía computarizada
#30	AnnotatorNotes T35	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T36	PROC 1825 1828	TAC
#31	AnnotatorNotes T36	C0040405; X-Ray Computed Tomography; Diagnostic Procedure
T37	PROC 1832 1852	resonancia magnética
#32	AnnotatorNotes T37	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T38	PROC 1854 1856	RM
#33	AnnotatorNotes T38	C0024485; Magnetic Resonance Imaging; Diagnostic Procedure
T39	PROC 1905 1927	estudios radiográficos
T40	DISO 1960 1979	neoplasias malignas
#34	AnnotatorNotes T40	C0006826; Malignant Neoplasms; Neoplastic Process
T41	DISO 2044 2071	carcinoma in situ de cérvix
#35	AnnotatorNotes T41	C0851140; Carcinoma in situ of uterine cervix; Neoplastic Process
T42	DISO 2073 2102	carcinoma de piel no melanoma
#36	AnnotatorNotes T42	C0699893; Skin carcinoma; Neoplastic Process
T44	DISO 2104 2141	adenocarcinoma ductal in situ de mama
T45	ANAT 2137 2141	mama
#38	AnnotatorNotes T45	C0006141; Breast; Body Part, Organ, or Organ Component | C1268990; Entire breast; Body Part, Organ, or Organ Component
T46	DISO 2143 2169	cáncer de próstata in situ
T47	DISO 2171 2187	cáncer de vejiga
#39	AnnotatorNotes T47	C0005684; Malignant neoplasm of urinary bladder; Neoplastic Process
T48	DISO 2209 2224	cáncer de útero
#40	AnnotatorNotes T48	C0153567; Uterine Cancer; Neoplastic Process
T49	DISO 2271 2278	tumores
#41	AnnotatorNotes T49	C0006826; Malignant Neoplasms; Neoplastic Process | C0027651; Neoplasms; Neoplastic Process | C0577559; Mass of body structure; Finding
T50	DISO 2303 2313	enfermedad
#42	AnnotatorNotes T50	C0012634; Disease; Disease or Syndrome [Positive entity (double negation context)]
T51	DISO 2342 2367	Enfermedad cardiovascular
#43	AnnotatorNotes T51	C0007222; Cardiovascular Diseases; Disease or Syndrome
T52	PROC 2239 2247	tratados
#44	AnnotatorNotes T52	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T53	DISO 2446 2450	SIDA
#45	AnnotatorNotes T53	C0001175; Acquired Immunodeficiency Syndrome; Disease or Syndrome
T54	DISO 2506 2515	trastorno
#46	AnnotatorNotes T54	C0012634; Disease; Disease or Syndrome
T55	CHEM 2620 2628	fármacos
#47	AnnotatorNotes T55	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T56	DISO 2453 2486	Condiciones médicas concomitantes
T57	PROC 2750 2759	protocolo
#48	AnnotatorNotes T57	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T58	ANAT 175 181	Pulmón
#49	AnnotatorNotes T58	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T59	ANAT 185 192	Células
#50	AnnotatorNotes T59	C0007634; Cells; Cell | C1269647; Entire cell; Cell
T60	DISO 210 221	Metastásico
#51	AnnotatorNotes T60	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T61	ANAT 254 263	somáticas
#52	AnnotatorNotes T61	C1257909; Diploid Cell; Cell
T62	DISO 223 228	NSCLC
#53	AnnotatorNotes T62	C0007131; Non-Small Cell Lung Carcinoma; Neoplastic Process
T63	ANAT 495 501	PULMÓN
#54	AnnotatorNotes T63	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T64	ANAT 505 516	MICROCÍTICO
#55	AnnotatorNotes T64	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T65	DISO 535 546	METASTÁSICO
#56	AnnotatorNotes T65	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T66	ANAT 572 581	SOMÁTICAS
#57	AnnotatorNotes T66	C1257909; Diploid Cell; Cell
T67	ANAT 733 739	pulmón
#58	AnnotatorNotes T67	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T68	ANAT 844 850	PULMÓN
#59	AnnotatorNotes T68	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T69	ANAT 854 865	MICROCÍTICO
#60	AnnotatorNotes T69	C1514085; Neoplastic Small Cell; Cell | C1518241; Malignant Small Cell; Cell
T70	DISO 884 895	METASTÁSICO
#61	AnnotatorNotes T70	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T71	DISO 1057 1068	metastásico
#62	AnnotatorNotes T71	C0027627; Neoplasm Metastasis; Neoplastic Process | C4255448; Metastasis; Pathologic Function
T72	PROC 1755 1763	tratadas
#63	AnnotatorNotes T72	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T73	DISO 1723 1741	Metástasis del SNC
T74	ANAT 1738 1741	SNC
#64	AnnotatorNotes T74	C1269563; Entire central nervous system; Body System | C3714787; Central Nervous System; Body System
T75	ANAT 2065 2071	cérvix
#65	AnnotatorNotes T75	C0007874; Cervix Uteri; Body Part, Organ, or Organ Component | C1278987; Entire cervix uteri; Body Part, Organ, or Organ Component
T76	ANAT 2086 2090	piel
#66	AnnotatorNotes T76	C1123023; Skin; Body System | C1278993; Entire skin; Body System
T77	ANAT 2119 2125	ductal
#67	AnnotatorNotes T77	C0687028; Duct (organ) structure; Body Part, Organ, or Organ Component
T78	ANAT 2153 2161	próstata
#68	AnnotatorNotes T78	C0033572; Prostate; Body Part, Organ, or Organ Component | C1278980; Entire prostate; Body Part, Organ, or Organ Component
T79	ANAT 2181 2187	vejiga
#69	AnnotatorNotes T79	C0005682; Urinary Bladder; Body Part, Organ, or Organ Component
T80	ANAT 2219 2224	útero
#70	AnnotatorNotes T80	C0042149; Uterus; Body Part, Organ, or Organ Component | C1269032; Entire uterus; Body Part, Organ, or Organ Component
T81	ANAT 2353 2367	cardiovascular
#71	AnnotatorNotes T81	C0007226; Cardiovascular system; Body System | C3887460; Cardiovascular; Body Location or Region
T82	DISO 2384 2404	Positividad para VIH
#72	AnnotatorNotes T82	C4759637; HIV positive status; Finding
T83	DISO 2418 2428	patologías
#73	AnnotatorNotes T83	C0677042; Pathology processes; Pathologic Function
T84	Date 12 16	2017
T85	LIVB 151 160	pacientes
#74	AnnotatorNotes T85	C0030705; Patients; Patient or Disabled Group
T88	LIVB 471 480	PACIENTES
#75	AnnotatorNotes T88	C0030705; Patients; Patient or Disabled Group
T89	Neg_cue 502 504	NO
T91	Neg_cue 851 853	NO
T93	Neg_cue 969 971	no
T95	Age 1136 1143	18 años
T97	PHYS 1311 1321	recuperado
#76	AnnotatorNotes T97	C2004454; Recovery - healing process; Organism Function
T98	Date 1389 1397	reciente
T99	Duration 1463 1475	≥ 12 semanas
T100	LIVB 1482 1513	mujeres potencialmente fértiles
#77	AnnotatorNotes T100	C4324275; Woman of childbearing potential; Population Group
T102	LIVB 1520 1527	varones
#78	AnnotatorNotes T102	C0025266; Male population group; Population Group
T103	Neg_cue 1624 1640	Incapacidad para
T104	Route 1664 1672	vía oral
#79	AnnotatorNotes T104	C1527415; Oral Route of Drug administration; Functional Concept
T105	LIVB 1675 1720	Mujeres embarazadas o en período de lactancia
#80	AnnotatorNotes T105	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T106	Neg_cue 1752 1754	no
T107	Duration 1983 1993	los 5 años
T108	Neg_cue 2032 2043	exceptuando
T111	Duration 2322 2339	al menos dos años
T112	LIVB 2401 2404	VIH
#81	AnnotatorNotes T112	C0019682; HIV; Virus
T113	LIVB 2544 2552	paciente
#82	AnnotatorNotes T113	C0030705; Patients; Patient or Disabled Group
T86	PHYS 1415 1433	Función de órganos
#83	AnnotatorNotes T86	C1254358; Organ or Tissue Function; Organ or Tissue Function
T87	PHYS 1711 1720	lactancia
#84	AnnotatorNotes T87	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T90	PHYS 1683 1694	embarazadas
#85	AnnotatorNotes T90	C0032961; Pregnancy; Organism Function
T96	PROC 1154 1170	Estado funcional
#86	AnnotatorNotes T96	C4525818; Clinical Performance Status; Health Care Activity | C3694602; functional status of patient; Therapeutic or Preventive Procedure
T92	PROC 1098 1127	histológica o citológicamente
#87	AnnotatorNotes T92	C1305671; Cytology procedure; Laboratory Procedure + C0344441; Histology Procedure; Laboratory Procedure
A1	Assertion T64 Negated
A2	Assertion T69 Negated
A3	Assertion T26 Negated
A5	Assertion T33 Negated
A6	Assertion T104 Negated
A7	Assertion T72 Negated
A8	Assertion T41 Negated
A13	Assertion T42 Negated
A9	Assertion T44 Negated
A14	Assertion T46 Negated
A15	Assertion T47 Negated
A16	Assertion T48 Negated
A17	Assertion T49 Negated
A11	Status T40 History_of
A12	Status T54 History_of
A19	Status T29 History_of
A20	Status T39 History_of
A21	Status T41 History_of
A22	Status T42 History_of
A18	Status T44 History_of
A24	Status T46 History_of
A25	Status T47 History_of
A26	Status T48 History_of
A27	Status T49 History_of
A10	Status T50 History_of
#88	AnnotatorNotes T2	C0511730; Identify product efficacy and safety issues; Health Care Activity
#89	AnnotatorNotes T8	C1519042; Phase II/III Trial; Research Activity 
#90	AnnotatorNotes T73	C0686377; CNS metastases; Neoplastic Process
#91	AnnotatorNotes T39	C1306645; Plain x-ray; Diagnostic Procedure | C1962945; Radiographic imaging procedure; Diagnostic Procedure
#92	AnnotatorNotes T56	C0243087; concomitant disease; Pathologic Function
#93	AnnotatorNotes T98	C0332185; Recent; Temporal Concept
T94	Quantifier_or_Qualifier 196 204	pequeñas
A28	Assertion T94 Negated
#94	AnnotatorNotes T94	C0700321; Small; Quantitative Concept
T101	Neg_cue 193 195	no
T109	Quantifier_or_Qualifier 942 951	resecable
A29	Assertion T109 Negated
#95	AnnotatorNotes T109	C1514888; Resectable; Qualitative Concept
T110	Neg_cue 939 941	no
T114	Neg_cue 2294 2302	libre de
A30	Assertion T50 Negated
T115	Quantifier_or_Qualifier 1505 1513	fértiles
A31	Assertion T115 Speculated
T116	Spec_cue 1490 1504	potencialmente
R1	Negation Arg1:T101 Arg2:T94	
R2	Negation Arg1:T110 Arg2:T109	
R3	Negation Arg1:T93 Arg2:T26	
R4	Speculation Arg1:T116 Arg2:T115	
R5	Has_Quantifier_or_Qualifier Arg1:T100 Arg2:T115	
R6	Negation Arg1:T103 Arg2:T33	
R7	Negation Arg1:T103 Arg2:T104	
R8	Has_Route_or_Mode Arg1:T33 Arg2:T104	
R9	Negation Arg1:T106 Arg2:T72	
R10	Negation Arg1:T108 Arg2:T41	
R11	Negation Arg1:T108 Arg2:T42	
R12	Negation Arg1:T114 Arg2:T50	
R13	Has_Duration_or_Interval Arg1:T50 Arg2:T111	
R14	Negation Arg1:T108 Arg2:T44	
R15	Negation Arg1:T108 Arg2:T46	
R16	Negation Arg1:T108 Arg2:T47	
R17	Negation Arg1:T108 Arg2:T48	
T43	Quantifier_or_Qualifier 2191 2207	estadio limitado
A23	Assertion T43 Negated
R18	Has_Quantifier_or_Qualifier Arg1:T47 Arg2:T43	
T117	Quantifier_or_Qualifier 2228 2237	estadio I
A32	Assertion T117 Negated
R19	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T117	
R20	Negation Arg1:T108 Arg2:T49	
R21	Has_Duration_or_Interval Arg1:T49 Arg2:T111	
T118	Spec_cue 2700 2716	Incapacidad para
T119	Observation 2717 2759	cumplir los otros requisitos del protocolo
A33	Assertion T119 Negated
R22	Speculation Arg1:T118 Arg2:T119	
R23	Negation Arg1:T89 Arg2:T64	
R24	Negation Arg1:T91 Arg2:T69	
T120	Quantifier_or_Qualifier 108 117	múltiples
#37	AnnotatorNotes T120	C0439064; Numerous; Quantitative Concept
R25	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T120	
R26	Experiences Arg1:T85 Arg2:T3	
R27	Experiences Arg1:T85 Arg2:T4	
R28	Experiences Arg1:T85 Arg2:T5	
R29	Location_of Arg1:T58 Arg2:T5	
R30	Has_Quantifier_or_Qualifier Arg1:T59 Arg2:T94	
R31	Experiences Arg1:T85 Arg2:T60	
R32	Before Arg1:T5 Arg2:T60	
R33	Location_of Arg1:T58 Arg2:T62	
R34	Overlap Arg1:T5 Arg2:T6	
R35	Overlap Arg1:T62 Arg2:T6	
R36	Location_of Arg1:T61 Arg2:T6	
T121	Spec_cue 264 279	susceptibles de
T122	Observation 280 294	ser detectadas
A4	Assertion T122 Speculated
#96	AnnotatorNotes T122	C0442726; Detected (finding); Finding
R37	Location_of Arg1:T7 Arg2:T122	
R38	Speculation Arg1:T121 Arg2:T122	
R39	Has_Quantifier_or_Qualifier Arg1:T6 Arg2:T122	
R40	Experiences Arg1:T85 Arg2:T6	
T123	Quantifier_or_Qualifier 420 429	MÚLTIPLES
#97	AnnotatorNotes T123	C0439064; Numerous; Quantitative Concept
R41	Has_Quantifier_or_Qualifier Arg1:T10 Arg2:T123	
R42	Experiences Arg1:T88 Arg2:T10	
R43	Experiences Arg1:T88 Arg2:T11	
R44	Experiences Arg1:T88 Arg2:T12	
R45	Experiences Arg1:T88 Arg2:T13	
R46	Experiences Arg1:T88 Arg2:T65	
R47	Experiences Arg1:T88 Arg2:T14	
R48	Location_of Arg1:T66 Arg2:T14	
T124	Observation 594 604	DETECTADAS
#98	AnnotatorNotes T124	C0442726; Detected (finding); Finding
R49	Location_of Arg1:T16 Arg2:T124	
R50	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T124	
R51	Before Arg1:T12 Arg2:T65	
R52	Before Arg1:T13 Arg2:T65	
R53	Location_of Arg1:T63 Arg2:T12	
R54	Location_of Arg1:T63 Arg2:T13	
T125	Quantifier_or_Qualifier 524 532	AVANZADO
#99	AnnotatorNotes T125	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R55	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T125	
R56	Has_Quantifier_or_Qualifier Arg1:T13 Arg2:T125	
R57	Before Arg1:T62 Arg2:T60	
R58	Overlap Arg1:T12 Arg2:T14	
R59	Overlap Arg1:T13 Arg2:T14	
T126	Quantifier_or_Qualifier 694 702	avanzado
#100	AnnotatorNotes T126	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R60	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T126	
R61	Before Arg1:T19 Arg2:T15	
R62	Location_of Arg1:T67 Arg2:T20	
R63	Location_of Arg1:T67 Arg2:T19	
R64	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T126	
R65	Before Arg1:T20 Arg2:T15	
T127	Quantifier_or_Qualifier 750 760	diseminado
#101	AnnotatorNotes T127	C0205221; Disseminated; Spatial Concept | C1522484; metastatic qualifier; Functional Concept | C0036525; Metastatic to; Functional Concept
T128	CONC 763 792	áreas cercanas a los pulmones
R66	Location_of Arg1:T128 Arg2:T127	
T129	Quantifier_or_Qualifier 795 800	otros
#102	AnnotatorNotes T129	C0205394; Other; Qualitative Concept
R67	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T129	
R68	Location_of Arg1:T22 Arg2:T127	
R69	Has_Quantifier_or_Qualifier Arg1:T20 Arg2:T127	
R70	Has_Quantifier_or_Qualifier Arg1:T19 Arg2:T127	
R71	Location_of Arg1:T68 Arg2:T23	
R72	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T109	
R73	Location_of Arg1:T68 Arg2:T24	
R74	Before Arg1:T23 Arg2:T70	
R75	Before Arg1:T24 Arg2:T70	
T130	Quantifier_or_Qualifier 873 881	AVANZADO
#103	AnnotatorNotes T130	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R76	Has_Quantifier_or_Qualifier Arg1:T23 Arg2:T130	
R77	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T130	
T131	Quantifier_or_Qualifier 955 967	estadio IIIb
R78	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T131	
T132	Quantifier_or_Qualifier 1030 1038	avanzado
#104	AnnotatorNotes T132	C0205179; Advanced phase; Qualitative Concept | C1522484; metastatic qualifier; Functional Concept
R79	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T132	
R80	Before Arg1:T25 Arg2:T71	
T133	Quantifier_or_Qualifier 1045 1055	estadio IV
R81	Has_Quantifier_or_Qualifier Arg1:T25 Arg2:T133	
R82	Before Arg1:T92 Arg2:T27	
T134	CONC 1175 1209	Eastern Cooperative Oncology Group
#105	AnnotatorNotes T134	C1520224; ECOG performance status; Intellectual Product
T135	CONC 1211 1215	ECOG
#106	AnnotatorNotes T135	C1520224; ECOG performance status; Intellectual Product
R84	Used_for Arg1:T134 Arg2:T96	
R85	Used_for Arg1:T135 Arg2:T96	
T136	Result_or_Value 1217 1220	0-2
R86	Has_Result_or_Value Arg1:T134 Arg2:T136	
R87	Has_Result_or_Value Arg1:T135 Arg2:T136	
T137	CONC 1271 1292	criterios RECIST,v1.1
#107	AnnotatorNotes T137	C1709926; Response Evaluation Criteria in Solid Tumors; Intellectual Product
T138	Quantifier_or_Qualifier 1322 1335	adecuadamente
#108	AnnotatorNotes T138	C0205411; Adequate; Qualitative Concept
R88	Has_Quantifier_or_Qualifier Arg1:T97 Arg2:T138	
R90	Overlap Arg1:T29 Arg2:T98	
R91	Before Arg1:T30 Arg2:T97	
#109	AnnotatorNotes T29	C1515119; Systemic Therapy; Therapeutic or Preventive Procedure | C1517925; Local Therapy; Therapeutic or Preventive Procedure
R92	Location_of Arg1:T31 Arg2:T86	
T139	Observation 1343 1350	efectos
#110	AnnotatorNotes T139	C1518681; Outcome of Therapy; Finding (?)
R93	Before Arg1:T139 Arg2:T97	
R94	Causes Arg1:T29 Arg2:T139	
T140	Observation 1415 1442	Función de órganos adecuada
T141	CONC 1445 1462	Esperanza de vida
#111	AnnotatorNotes T141	C0023671; Life Expectancy; Group Attribute
R89	Has_Duration_or_Interval Arg1:T141 Arg2:T99	
T142	Observation 1540 1550	dispuestos
#112	AnnotatorNotes T142	C0600109; Willing; Finding
R95	Has_Quantifier_or_Qualifier Arg1:T100 Arg2:T142	
R96	Has_Quantifier_or_Qualifier Arg1:T102 Arg2:T142	
R97	Overlap Arg1:T142 Arg2:T32	
R98	Experiences Arg1:T100 Arg2:T32	
R99	Experiences Arg1:T102 Arg2:T32	
T143	Quantifier_or_Qualifier 1586 1596	aceptables
R100	Has_Quantifier_or_Qualifier Arg1:T32 Arg2:T143	
#113	AnnotatorNotes T143	C1879533; Acceptable; Qualitative Concept
R101	Experiences Arg1:T105 Arg2:T90	
R102	Experiences Arg1:T105 Arg2:T87	
R103	Location_of Arg1:T74 Arg2:T73	
R114	Before Arg1:T39 Arg2:T34	
R115	Before Arg1:T39 Arg2:T35	
R116	Before Arg1:T39 Arg2:T36	
R117	Before Arg1:T39 Arg2:T37	
R118	Before Arg1:T39 Arg2:T38	
T144	PROC 1890 1899	selección
#114	AnnotatorNotes T144	C0242802; Patient Selection; Research Activity
R119	Overlap Arg1:T38 Arg2:T144	
R120	Overlap Arg1:T37 Arg2:T144	
R121	Overlap Arg1:T36 Arg2:T144	
R122	Overlap Arg1:T35 Arg2:T144	
R123	Overlap Arg1:T34 Arg2:T144	
R124	Before Arg1:T39 Arg2:T144	
T145	Quantifier_or_Qualifier 1742 1749	activas
#115	AnnotatorNotes T145	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R125	Has_Quantifier_or_Qualifier Arg1:T73 Arg2:T145	
R126	Overlap Arg1:T40 Arg2:T107	
T146	Quantifier_or_Qualifier 1954 1959	otras
A34	Status T146 History_of
#116	AnnotatorNotes T146	C0205394; Other; Qualitative Concept
R127	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T146	
T147	PROC 2007 2016	selección
#117	AnnotatorNotes T147	C0242802; Patient Selection; Research Activity
R128	Before Arg1:T40 Arg2:T147	
R129	Location_of Arg1:T75 Arg2:T41	
R130	Location_of Arg1:T76 Arg2:T42	
R131	Location_of Arg1:T77 Arg2:T44	
R132	Location_of Arg1:T45 Arg2:T44	
R133	Location_of Arg1:T78 Arg2:T46	
R134	Location_of Arg1:T79 Arg2:T47	
R135	Negation Arg1:T108 Arg2:T43	
R136	Location_of Arg1:T80 Arg2:T48	
R137	Negation Arg1:T108 Arg2:T117	
T148	Quantifier_or_Qualifier 2248 2261	adecuadamente
R138	Has_Quantifier_or_Qualifier Arg1:T52 Arg2:T148	
#118	AnnotatorNotes T148	C0205411; Adequate; Qualitative Concept
#119	AnnotatorNotes T46	C0154088; Carcinoma in situ of prostate; Neoplastic Process (?) | C0747993; PROSTATE CANCER ADENOCARCINOMA IN SITU; Neoplastic Process (?)
R139	Location_of Arg1:T81 Arg2:T51	
T149	Quantifier_or_Qualifier 2368 2381	significativa
#120	AnnotatorNotes T149	C1546944; Event Seriousness - Significant; Qualitative Concept
R140	Has_Quantifier_or_Qualifier Arg1:T51 Arg2:T149	
R141	Causes Arg1:T112 Arg2:T82	
R142	Overlap Arg1:T83 Arg2:T53	
T150	Observation 2556 2562	riesgo
R143	Experiences Arg1:T113 Arg2:T150	
R144	Before Arg1:T56 Arg2:T150	
R145	Before Arg1:T54 Arg2:T150	
R146	Used_for Arg1:T55 Arg2:T1	
R147	Before Arg1:T1 Arg2:T150	
T151	Observation 2647 2685	afecten la interpretación de los datos
R148	Before Arg1:T56 Arg2:T151	
R149	Before Arg1:T54 Arg2:T151	
R150	Experiences Arg1:T113 Arg2:T56	
R151	Experiences Arg1:T113 Arg2:T54	
R152	Experiences Arg1:T113 Arg2:T1	
R153	Location_of Arg1:T31 Arg2:T140	
A35	Assertion T52 Negated
R154	Negation Arg1:T108 Arg2:T52	
A36	Assertion T148 Negated
R155	Negation Arg1:T108 Arg2:T148	
#121	AnnotatorNotes T150	C0559571; At risk; Finding
R156	Experiences Arg1:T85 Arg2:T62	
#122	AnnotatorNotes T17	C1511226; Blood Screening; Laboratory Procedure (?)
A37	Experiencer T85 Patient
A38	Experiencer T88 Patient
A39	Experiencer T100 Patient
A40	Experiencer T102 Patient
A41	Experiencer T105 Patient
A42	Experiencer T113 Patient
A43	Assertion T1 Hypothetical
A44	Assertion T55 Hypothetical
